今日要闻！软通动力入选深证50指数样本：科技实力与可持续成长获认可

软通动力入选深证50指数样本：科技实力与可持续成长获认可

北京，2024年6月16日 - 近日，深市系列核心指数样本股定期调整结果出炉，软通动力（301236.SZ）被调入深证50指数，并将于6月17日收市后生效。这标志着软通动力在科技实力、创新能力和可持续发展方面获得了市场高度认可，成为深市50强之一。

深证50指数是反映深圳证券交易所最具市场代表性和流动性的50只优质上市股票的成份指数，被誉为“深市蓝筹股晴雨表”。入选该指数，不仅是对企业综合实力的权威认可，更能有效提升公司知名度和影响力，为企业发展带来新的机遇和挑战。

软通动力此次入选深证50指数，是其多年来深耕数字技术服务领域，持续创新、不断突破的必然结果。近年来，软通动力以“软硬一体”战略为引领，积极布局云计算、大数据、人工智能等新兴技术领域，不断提升核心竞争力，为客户提供全方位、高水平的数字技术服务。

公司在金融科技、智能终端、智能汽车、数字能源、新快消零售、大健康、智慧教育、智能制造、绿色算力等战略新兴行业积累了丰富的经验和深厚的基础，为行业数字化转型提供了强有力的支撑。

软通动力表示，入选深证50指数是公司发展历程上的一座重要里程碑，也是对公司未来发展的鞭策和鼓励。公司将继续坚持创新驱动，不断提升核心竞争力，为客户创造更大价值，为股东带来更高回报，为深市资本市场发展贡献更大的力量。

关于软通动力

软通动力（股票代码：301236）是国内领先的数字技术服务商，致力于为客户提供全方位、高水平的数字技术服务，助力客户数字化转型升级。公司拥有超过3万名员工，在全球设有8大交付基地和4个区域中心，为全球超过5000家客户提供服务。

软通动力始终坚持科技创新，积极布局云计算、大数据、人工智能等新兴技术领域，不断提升核心竞争力。公司在金融科技、智能终端、智能汽车、数字能源、新快消零售、大健康、智慧教育、智能制造、绿色算力等战略新兴行业积累了丰富的经验和深厚的基础，为行业数字化转型提供了强有力的支撑。

软通动力连续多年荣获中国上市公司百强、中国企业信息化百强、中国软件百强等荣誉称号。公司致力于为客户创造更大价值，为股东带来更高回报，为社会创造更大效益，为中国数字经济发展贡献更大的力量。

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.